Tradewinds Capital Management’s GoodRx Holdings GDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-50
Closed -$282 503
2023
Q3
$282 Hold
50
﹤0.01% 451
2023
Q2
$276 Hold
50
﹤0.01% 428
2023
Q1
$313 Hold
50
﹤0.01% 429
2022
Q4
$233 Hold
50
﹤0.01% 474
2022
Q3
$0 Hold
50
﹤0.01% 453
2022
Q2
$0 Hold
50
﹤0.01% 554
2022
Q1
$1K Hold
50
﹤0.01% 718
2021
Q4
$2K Hold
50
﹤0.01% 669
2021
Q3
$2K Buy
+50
New +$1.81K ﹤0.01% 650

Other funds holding GDRX

Tradewinds Capital Management's GDRX Position: Q4 2023 in Review

Tradewinds Capital Management sold out of GoodRx Holdings (GDRX) in Q4 2023, closing a stake of 50 shares — an estimated $282 sold.

Tradewinds Capital Management first reported a position in GDRX in Q3 2021 and held it in 9 quarters. The position peaked at $2K in Q4 2021. 143 funds tracked by Wall St. Rank hold GDRX as of Q4 2023.

  • Tradewinds Capital Management reported no remaining GoodRx Holdings position as of Q4 2023 after selling out during the quarter.
  • Tradewinds Capital Management sold 50 GoodRx Holdings shares in Q4 2023, an estimated $282.
  • Tradewinds Capital Management first reported a position in GoodRx Holdings in Q3 2021 and held it in 9 quarters.
  • Tradewinds Capital Management's GoodRx Holdings position peaked at $2K in Q4 2021.
  • 143 funds tracked by Wall St. Rank held GoodRx Holdings as of Q4 2023.

Based on Tradewinds Capital Management's 13F filing for Q4 2023, filed 1 Feb 2024.